.
BioEnterprise

Abeona Therapeutics Receives Breakthrough Therapy Designation Status from FDA

Abeona Therapeutics receives Breakthrough Therapy designation status from the FDA for its gene therapy technology for patients with Recessive Dystrophic Epidermolysis Bullosa, or RDEB.

Read More  >